Advanced Search

UAM_Biblioteca

Now showing items 1-10 of 1895

Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia

Roche, Olga; Deguiz, María Laura; Tiana, María; Galiana-Ribote, Clara; Martínez-Alcázar, Daniel; Rey-Serra, Carlos; Ranz-Ribeiro, Beatriz; Casitas, Raquel; Galera, Raúl; Fernández-Navarro, Isabel; Sánchez-Cuéllar, Silvia; Bernard, Virginie; Ancochea, Julio; Wasserman, Wyeth W.; García-Rio, Francisco; Jiménez, Benilde; del Peso, Luis
2016-11-02

Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

Cruz-Bermúdez, Alberto; Laza-Briviesca, Raquel; Vicente-Blanco, Ramiro J.; García-Grande, Aránzazu; Coronado, Maria José; Laine-Menéndez, Sara; Palacios-Zambrano, Sara; Moreno-Villa, M. Rocío; Martín Ruiz-Valdepeñas, Asunción; Lendinez, Cristina; Romero, Atocha; Franco, Fernando; Calvo, Virginia; Alfaro, Cristina; Martín Acosta, Paloma; Salas, Clara; Garcia, José Miguel; Provencio, Mariano
2019-05-14

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives

Díaz-López, Antonio; Moreno-Bueno, Gema; Cano, Amparo
2014-04-25

Protein tyrosine phosphatase 1B modulates GSK3b/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity

Mobasher, M. A.; González-Rodríguez, Águeda; Santamaría, Beatríz; Ramos, Sonia; Martín, María Ángeles Luengo; Goya, Luis; Rada, Patricia; Letzig, Lynda G.; James, Laura Phillips; Cuadrado, Antonio; Martín Pérez, Jorge; Simpson, Kenneth James; Muntané, Jordi; Valverde, Ángela M.
2013-05-01

Epitope mapping of antibodies to alpha-synuclein in LRRK2 mutation carriers, idiopathic parkinson disease patients, and healthy controls

Alvarez-Castelao, Beatriz; Gorostidi, Ana; Ruíz-Martínez, Javier; De Munaín, Adolfo López; Castaño, José G.
2014-07-15

Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism

Jaźwa, Agnieszka; Rojo, Ana I.; Innamorato, Nadia G.; Hesse, Marlen; Fernández-Ruíz, Javier Javier; Cuadrado, Antonio
2011-06-15

1
2
3
4
. . .
190

UAM_Biblioteca

Advanced Search

Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia

Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives

Protein tyrosine phosphatase 1B modulates GSK3b/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity

Epitope mapping of antibodies to alpha-synuclein in LRRK2 mutation carriers, idiopathic parkinson disease patients, and healthy controls

Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism

Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis

CNVassoc: Association analysis of CNV data using R

Generation of a human iPSC line from a patient with a defect of intergenomic communication

eEF1A mediates the nuclear export of SNAG-containing proteins via the Exportin5-aminoacyl-tRNA complex

UAM_Biblioteca

Advanced Search

Filters

Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia

Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition

Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives

Protein tyrosine phosphatase 1B modulates GSK3b/Nrf2 and IGFIR signaling pathways in acetaminophen-induced hepatotoxicity

Epitope mapping of antibodies to alpha-synuclein in LRRK2 mutation carriers, idiopathic parkinson disease patients, and healthy controls

Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism

Levels of active tyrosine kinase receptor determine the tumor response to Zalypsis

CNVassoc: Association analysis of CNV data using R

Generation of a human iPSC line from a patient with a defect of intergenomic communication

eEF1A mediates the nuclear export of SNAG-containing proteins via the Exportin5-aminoacyl-tRNA complex